Cargando…

Therapy as prevention toward HCV elimination in maintenance hemodialysis: a multi-center, prospective cohort study

BACKGROUND: The World Health Organization has established interim guidance for hepatitis C virus (HCV) elimination. We aimed to prove the concept of “treatment as prevention” by conducting a prospective HCV elimination program for hemodialysis (HD) patients. METHODS: A universal HCV screen was launc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Chung-Feng, Dai, Chia-Yen, Wang, Chih-Wen, Liang, Po-Cheng, Wei, Yu-Ju, Tsai, Pei-Chien, Jang, Tyng-Yuan, Hsu, Po-Yao, , Jia-Jung Lee, Niu, Sheng-Wen, Huang, Jiun-Chi, Yeh, Ming-Lun, Huang, Ching-I, Hsieh, Ming-Yen, Lin, Yi-Hung, Chen, Szu-Chia, Chiu, Yi-Wen, Huang, Jee-Fu, Chang, Jer-Ming, Hwang, Shang-Jyh, Chuang, Wan-Long, Yu, Ming-Lung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689175/ https://www.ncbi.nlm.nih.gov/pubmed/38046041 http://dx.doi.org/10.1093/ckj/sfad138

Ejemplares similares

Towards a safe hospital: hepatitis C in-hospital micro-elimination program (HCV-HELP study)
por: Huang, Jee-Fu, et al.
Publicado: (2021)

The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis C
por: Lee, Jia-Jung, et al.
Publicado: (2020)

A people-centered decentralized outreach model toward HCV micro-elimination in hyperendemic areas: COMPACT study in SARS Co–V2 pandemic
por: Huang, Ching-I, et al.
Publicado: (2023)

Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis
por: Hsu, Po-Yao, et al.
Publicado: (2021)

Discrepancy between Serological and Virological Analysis of Viral Hepatitis in Hemodialysis Patients
por: Chang, Jer-Ming, et al.
Publicado: (2014)

Association of Relatives of Hemodialysis Patients with Metabolic Syndrome, Albuminuria and Framingham Risk Score
por: Huang, Jiun-Chi, et al.
Publicado: (2014)

Anti-HCV antibody titer highly predicts HCV viremia in patients with hepatitis B virus dual-infection
por: Liu, Hung-Yin, et al.
Publicado: (2021)

COVID-19 Vaccines in Patients with Maintenance Hemodialysis
por: Yen, Cheng-Chieh, et al.
Publicado: (2021)

Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes
por: Huang, Ching-I, et al.
Publicado: (2018)

Itemization difference of patient-reported outcome in patients with chronic liver disease
por: Lin, Ming-Chieh, et al.
Publicado: (2022)

Effects of Achieving SVR on Clinical Characteristics and Surgical Outcomes in Patients Who Developed Early-Stage HCV-Related Hepatocellular Carcinoma and Received Curative Resection: Preoperative versus Postoperative SVR
por: Hsu, Po-Yao, et al.
Publicado: (2022)

Significant amelioration of hepatitis C virus infection in a hyperendemic area: longitudinal evidence from the COMPACT Study in Taiwan
por: Tsai, Pei-Chien, et al.
Publicado: (2021)

Association between Reduced Serum Zinc and Diastolic Dysfunction in Maintenance Hemodialysis Patients
por: Huang, Jiun-Chi, et al.
Publicado: (2021)

Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison
por: Chen, Chun-Ting, et al.
Publicado: (2022)

The performance of HCV GT plus RUO reagent in determining Hepatitis C virus genotypes in Taiwan
por: Huang, Ying-Chou, et al.
Publicado: (2021)

Changes in acoustic cardiographic parameters before and after hemodialysis are associated with overall and cardiovascular mortality in hemodialysis patients
por: Chung, Tung-Ling, et al.
Publicado: (2021)

Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy
por: Huang, Chung-Feng, et al.
Publicado: (2016)

Investigation of Acoustic Cardiographic Parameters before and after Hemodialysis
por: Tsai, Hui-Ju, et al.
Publicado: (2019)

Progression of Aortic Arch Calcification Is Associated with Overall and Cardiovascular Mortality in Hemodialysis
por: Chung, Wei-Shiuan, et al.
Publicado: (2020)

Dose Consideration of Lenvatinib’s Anti-Cancer Effect on Hepatocellular Carcinoma and the Potential Benefit of Combined Colchicine Therapy
por: Lin, Zu-Yau, et al.
Publicado: (2023)

Heart Rate Variability Change Before and After Hemodialysis is Associated with Overall and Cardiovascular Mortality in Hemodialysis
por: Chen, Szu-Chia, et al.
Publicado: (2016)

Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver Disease
por: Huang, Jee-Fu, et al.
Publicado: (2023)

Huge Gap Between Clinical Efficacy and Community Effectiveness in the Treatment of Chronic Hepatitis C: A Nationwide Survey in Taiwan
por: Yu, Ming-Lung, et al.
Publicado: (2015)

Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study
por: Huang, Chung-Feng, et al.
Publicado: (2019)

Role of Fracture Risk Assessment Tool and Bone Turnover Markers in Predicting All-Cause and Cardiovascular Mortality in Hemodialysis Patients
por: Wu, Pei-Yu, et al.
Publicado: (2022)

Persistent cryoglobulinemia after antiviral treatment is associated with advanced fibrosis in chronic hepatitis C patients
por: Batsaikhan, Batbold, et al.
Publicado: (2022)

Less liver fibrosis marker increment in overweight chronic hepatitis B patients observed by age-adjusted Fibrosis-4 Index
por: Liu, Ta-Wei, et al.
Publicado: (2020)

Association between Age and Changes in Heart Rate Variability after Hemodialysis in Patients with Diabetes
por: Niu, Sheng-Wen, et al.
Publicado: (2018)

Associations between Metabolic Syndrome and Obesity-Related Indices and Bone Mineral Density T-Score in Hemodialysis Patients
por: Wung, Chih-Hsuan, et al.
Publicado: (2021)

Association of hyperuricemia with disease severity in chronic hepatitis C patients
por: Jang, Tyng-Yuan, et al.
Publicado: (2018)

Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized Study
por: Yeh, Ming-Lun, et al.
Publicado: (2015)

Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis C
por: Yeh, Ming-Lun, et al.
Publicado: (2018)

Associations of Small Fiber Neuropathy with Geriatric Nutritional Risk Index and Arterial Stiffness in Hemodialysis
por: Kuo, Mei-Chuan, et al.
Publicado: (2020)

Four weeks of paritaprevir/ritonavir/ombitasvir plus dasabuvir encountering dengue fever resulted in sustained virological response in an HCV patient: A case report
por: Huang, Chung-Feng, et al.
Publicado: (2016)

Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals
por: Lin, Chuan-Pin, et al.
Publicado: (2021)

Abbott RealTime HBV Assay Is More Sensitive in Detection of Low Viral Load and Little Impacted by Drug Resistant Mutation in Chronic Hepatitis B Patients under Nucleot(s)ide Analogues Therapy
por: Yeh, Ming-Lun, et al.
Publicado: (2014)

The impact of an additional extra-hepatic primary malignancy on the outcomes of patients with hepatocellular carcinoma
por: Yeh, Ming-Lun, et al.
Publicado: (2017)

The IL-6/STAT3 pathway upregulates microRNA-125b expression in hepatitis C virus infection
por: Dai, Chia-Yen, et al.
Publicado: (2018)

Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR
por: Yeh, Ming-Lun, et al.
Publicado: (2021)

Association of Pulse Volume Recording at Ankle with Total and Cardiovascular Mortality in Hemodialysis Patients
por: Lee, Wen-Hsien, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5j8e77gsttr6qfho0n1o9kkqvd